Cocrystal Pharma (COCP) Change in Accured Expenses (2010 - 2026)
Cocrystal Pharma (COCP) reported Change in Accured Expenses of $10000.0 for Q1 2026, up 101.98% on a YoY basis from $4951.0 in Q1 2025, and down 98.53% sequentially from $682000.0 in Q4 2025.
Cocrystal Pharma (COCP) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Cocrystal Pharma (COCP) has 16 years of Change in Accured Expenses data on file, last reported at $10000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 101.98% year-over-year to $10000.0; the trailing twelve-month figure through Mar 2026 stood at $264000.0 (up 151.06% YoY), and the FY2025 full-year result was -$251000.0, up 71.96% from the prior year.
- Change in Accured Expenses fell to $10000.0 in Q1 2026, from $682000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $2.0 million in Q1 2023 to a low of -$1.5 million in Q2 2023.
- A 5-year average of $34647.1 and a median of $10000.0 in 2026 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 11435.29% in 2023, while the deepest fall reached 341.98% in 2023.
- Tracing COCP's Change in Accured Expenses over 5 years: stood at -$402000.0 in 2022, then surged by 402.49% to $1.2 million in 2023, then plunged by 61.18% to $472000.0 in 2024, then jumped by 44.49% to $682000.0 in 2025, then slumped by 98.53% to $10000.0 in 2026.
- Business Quant data shows COCP's Change in Accured Expenses at $10000.0 in Q1 2026, $682000.0 in Q4 2025, and -$320000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -16.74 Mn |
| 10 | Cocrystal Pharma | 12.57 Mn | 7.74 Mn | - | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 682,000.00 |
| Dec 31, 2025 | 682,000.00 |
| Sep 30, 2025 | -320,000.00 |
| Sep 30, 2025 | -320,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Jun 30, 2025 | -108,000.00 |
| Mar 31, 2025 | -505,000.00 |
| Mar 31, 2025 | -505,000.00 |
| Dec 31, 2024 | 472,000.00 |
| Dec 31, 2024 | 472,000.00 |
| Sep 30, 2024 | -748,000.00 |
| Sep 30, 2024 | -748,000.00 |
| Jun 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 264,000.00 |
| Mar 31, 2024 | -883,000.00 |
| Mar 31, 2024 | -883,000.00 |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |